Lysophosphatidic acid (LPA)-antibody (504B3)validation by free-solution assay and interferometry identifies off-target binding
Manisha Ray, Yasuyuki Kihara, Darryl J. Bornhop, Jerold J. M. Chun
This study validates an anti-LPA antibody (504B3) and finds it binds non-LPA lipids, suggesting potential off-target effects.
Lipids in Health and Disease · Apr 14, 2021Peer-reviewedMolecular Biology